Skip to main content
OpenTrials
Completed

NCT Number: NCT03749824

Investigation of Psychophysiological Response to Aversive Stimuli Over Time With Omega-3

This study investigates the psychophysiological responses to aversive stimuli in a population of 133 children clinically diagnosed with conduct disorder (CD) and/or attention-deficit/hyperactivity disorder (ADHD). Participants were administered with either omega-3 or placebo for a period of 6 months and were exposed to three stimuli every three months: 1) a loud sound, 2) threatening photographs from the International Affective Picture System (IAPS), and 3) the Trier Social Stress Task (TSST). Participants' psychophysiological features of heart rate and galvanic skin conductance were measured and analyzed in relation to their omega-3/placebo condition clinical diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects between ages 7 and 16 years
  • Subjects who fulfil all criteria for a DSM-IV diagnosis of ADHD, conduct disorder, or oppositional defiant disorder
  • Subjects with willingness to participate in a randomized, double-blind controlled trial
  • Subjects with complete written, informed parental consent and child assent
  • Subjects with IQ of 70 or more

Exclusion criteria

  • Subjects who have IQ in the below 70
  • Subjects who are younger than 7 years old or older than 16 years old
  • Those without written parental consent
  • Those with brain pathology such as serious head injury, epilepsy, etc.

Treatment and study plan

Omega-3

Dietary Supplement

Omega-3 supplement is a highly concentrated fish oil brain booster supplement that helps compensate for the neurocognitive and brain dysfunction which acts as a predisposition to antisocial and violent behaviour. Individuals with antisocial personality disorder have been found to show an 11% reduction in gray matter in the prefrontal cortex (Raine et al. 2001), and structural prefrontal impairments are hypothesised to result in disinhibition of limbic subcortical structures that give rise to aggressive behaviour. Omega-3 (specifically DHA) is known to play a key role in neuronal structure and function.

Placebo capsules

Dietary Supplement

Children in this group will be given two placebo capsules twice daily; at breakfast and at the evening meal for a total period of 6 months.

Primary outcomes

  1. Change from Baseline Heart Rate at 6 months

    Time frame: 7 minutes each at 0 months and 6 months

    For Trier Social Stress Task

  2. Change from Baseline Skin Conductance Response at 6 months

    Time frame: 4 minutes each at 0 months and 6 months

    For loud sound

  3. Change from Baseline Skin Conductance Response at 6 months

    Time frame: 4 minutes each at 0 months and 6 months

    For threatening photographs

Sponsors and collaborators

Lead sponsor

Yale-NUS College

Other

Registry information

Important dates

Study start
2011
Primary completion
2015
Study completion
2015
First posted
Nov 21, 2018
Registry last updated
Nov 21, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.